Latest Articles

Publication Date
Regarding "Is endometriosis staging related to the type and intensity of patients' complaints? A systematic review and meta-analysis".

Firstly, this meta-analysis[1] included a total of eight studies, seven of which used the rASRM classification, while only one applied the ENZIAN classification; the latter was not included in the …

Published: Jan. 9, 2026, midnight
Multidimensional factors increase menstrual distress in patients with endometriosis.

Endometriosis is a chronic endocrine and inflammatory disease commonly presenting with dysmenorrhea, pelvic pain, and/or infertility. Despite the importance of menstrual symptoms, the impact of menstruation on stress is still …

Published: Jan. 9, 2026, midnight
The Role of Astaxanthin as an Antioxidant and Anti-Inflammatory Agent in Human Health: A Systematic Review.

This systematic review aimed to summarize the effects of astaxanthin (ASX) supplementation on oxidative stress, inflammation, and metabolic regulation in human studies. A systematic search was conducted in Scopus, Web …

Published: Jan. 9, 2026, midnight
Acrivon Stock Sinks 29% Despite Positive Phase 2b Endometrial Cancer Data - Nasdaq

Acrivon Stock Sinks 29% Despite Positive Phase 2b Endometrial Cancer Data Nasdaq

Published: Jan. 8, 2026, 7:14 p.m.
Flu: Cases in Northern Ireland fall after December surge - BBC

Flu: Cases in Northern Ireland fall after December surge BBC

Published: Jan. 8, 2026, 4:36 p.m.
Dr. Jessica Ritch Opens EnRitched Gynecology, a New Membership-Based Women’s Health Practice - Rutland Herald

Dr. Jessica Ritch Opens EnRitched Gynecology, a New Membership-Based Women’s Health Practice Rutland Herald

Published: Jan. 8, 2026, 4:15 p.m.
Acrivon Therapeutics Announces Positive ACR-368 Phase 2b Endometrial Cancer Clinical Data with EU Expansion to Accelerate Enrollment, Initial ACR-2316 Clinical Data, and ACR-6840, its Next AP3-Enabled Development Candidate, Targeting CDK11 - The Manila Times

Acrivon Therapeutics Announces Positive ACR-368 Phase 2b Endometrial Cancer Clinical Data with EU Expansion to Accelerate Enrollment, Initial ACR-2316 Clinical Data, and ACR-6840, its Next AP3-Enabled Development Candidate, Targeting CDK11 …

Published: Jan. 8, 2026, 12:53 p.m.
Acrivon Therapeutics Announces Positive ACR-368 Phase 2b - GlobeNewswire

Acrivon Therapeutics Announces Positive ACR-368 Phase 2b GlobeNewswire

Published: Jan. 8, 2026, 12:30 p.m.
Small-Cap Acrivon Showcases Tumor Reduction and Clinical Advancement in Major Trials, Shares Decline - Bitget

Small-Cap Acrivon Showcases Tumor Reduction and Clinical Advancement in Major Trials, Shares Decline Bitget

Published: Jan. 8, 2026, 3:12 a.m.
Eutopic Endometrium Immune Changes Involved in Development and Progression of Endometriosis: A Review.

Numerous abnormalities of the endometriosis eutopic endometrium contribute to the initiation and development of ectopic lesions. It is also believed that among the complex causes of the disease, systemic immunological …

Published: Jan. 8, 2026, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!